GW-501516 (Cardarine) and SLU-PP-332 target distinct metabolic pathways — PPARδ and ERRα/γ respectively — making them a common pairing in comparative endurance and metabolic research. This bundled research option provides both compounds as high-purity liquid solutions for structured laboratory use.
GW-501516 (Cardarine) — 10mg/mL 30mL PPARδ agonist. Documented effects on fatty acid oxidation and mitochondrial biogenesis in preclinical models. Extensively referenced in endurance capacity and metabolic substrate utilization research.
SLU-PP-332 — 500mcg/mL 30mL ERRα/γ pan-agonist. Investigated in exercise mimetic research, with reported effects on oxidative metabolism and mitochondrial function in murine models. Newer compound with a smaller but growing body of published work.
Research Applications Comparative metabolic pathway analysis, PPARδ versus ERR signaling studies, mitochondrial biogenesis modeling, dual-compound interaction research.
Specifications Form: Lab-grade liquid solution · Volume: 30mL each · COA: Third-party verified · Storage: Cool, dry, away from light · Ships same day from Texas
For laboratory and preclinical research use only. Not for human or veterinary consumption.
Tien Wang (verified owner) –